Tak Yun - Concepedia

Author

Tak Yun

National Cancer Center ORCID

Also Known As

Seok Hyun Kim, T. B. Yun, T. Yun, Taek Seon Yun, Tak Yun, Tan Yen Yun, Yeejeong Kim

138

Publications

3.1K

Citations

H-Index

Concepts

All Affiliations

National Cancer Center Seoul National University Hospital Seoul National University Sungkyunkwan University University of Ulsan

About

Tak Yun is an author at National Cancer Center specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	26	918
2	Health Sciences	7	7	206
3	Public Health	2	2	42
4	Cell Biology	1	1	10
5	Cellular Therapies	1	1	19

Tak Yun

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
First-SIGNAL: First-Line Single-Agent Iressa Versus Gemcitabine and Cisplatin Trial in Never-Smokers With Adenocarcinoma of the Lung Ji‐Youn Han, Keunchil Park, Sang‐We Kim, Journal of Clinical Oncology	2012	732
A Randomized Phase II Study of Gefitinib Plus Simvastatin Versus Gefitinib Alone in Previously Treated Patients with Advanced Non–Small Cell Lung Cancer Ji‐Youn Han, Soo-Hyun Lee, Nam Jin Yoo, Clinical Cancer Research	2011	148
Non-organ specific cancer prevention of ginseng: a prospective study in Korea Tak Yun International Journal of Epidemiology	1998	140
Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial Anthony T.�C. Chan, V.H.F. Lee, R-L. Hong, Annals of Oncology	2022	100
A nomogram to predict brain metastasis as the first relapse in curatively resected non-small cell lung cancer patients Young‐Woong Won, Jungnam Joo, Tak Yun, Lung Cancer Surgical OncologyMedicineCancer RecurrenceCancer ManagementMultiple Pulmonary Nodule	2015	98
Comparison of 5-fluorouracil/leucovorin and capecitabine in preoperative chemoradiotherapy for locally advanced rectal cancer Dae Yong Kim, Kyung Hae Jung, Tae Hyun Kim, International Journal of Radiation OncologyBiologyPhysics Surgical OncologyRadiation TherapyGastrointestinal OncologyMedicinePreoperative Chemoradiotherapy	2006	92
Early neutrophil-to-lymphocyte ratio reduction as a surrogate marker of prognosis in never smokers with advanced lung adenocarcinoma receiving gefitinib or standard chemotherapy as first-line therapy Youngjoo Lee, Sun Hye Kim, Ji‐Youn Han, Journal of Cancer Research and Clinical Oncology Advanced Lung DiseaseMedicineStandard ChemotherapyImmunologySmoking Related Lung Disease	2012	91
Comparison of clinical outcome of patients with non-small-cell lung cancer harbouring epidermal growth factor receptor exon 19 or exon 21 mutations Young‐Woong Won, Ji‐Youn Han, Geon Kook Lee, Journal of Clinical Pathology	2011	74
Circulating Cell-Free DNA in Plasma of Never Smokers with Advanced Lung Adenocarcinoma Receiving Gefitinib or Standard Chemotherapy as First-Line Therapy Young Joo Lee, Kyong‐Ah Yoon, Ji‐Youn Han, Clinical Cancer Research	2011	70
Preoperative Chemoradiation With Cetuximab, Irinotecan, and Capecitabine in Patients With Locally Advanced Resectable Rectal Cancer: A Multicenter Phase II Study Sun Young Kim, Yong Sang Hong, Dae Yong Kim, International Journal of Radiation OncologyBiologyPhysics Surgical OncologyRadiation TherapyGastrointestinal OncologyColorectal SurgeryMedicine	2010	65

Page 1